![Veronica Byfield Sköld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Veronica Byfield Sköld
Directeur Général chez BioLamina AB
Postes actifs de Veronica Byfield Sköld
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioLamina AB
![]() BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Directeur Général | 01/10/2021 | - |
Directeur/Membre du Conseil | 01/04/2021 | - |
Historique de carrière de Veronica Byfield Sköld
Anciens postes connus de Veronica Byfield Sköld
Sociétés | Poste | Début | Fin |
---|---|---|---|
CLEMONDO GROUP AB | Sales & Marketing | 01/08/2020 | - |
Formation de Veronica Byfield Sköld
Royal Institute of Technology | Graduate Degree |
IHM Business School AB | Undergraduate Degree |
Statistiques
Internationale
Suède | 5 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CLEMONDO GROUP AB | Consumer Non-Durables |
Entreprise privées | 1 |
---|---|
BioLamina AB
![]() BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
- Bourse
- Insiders
- Veronica Byfield Sköld
- Expérience